EMA and FDA aim to slash Gaucher disease R&D costs
Proposals include multi-company trial.
X
EMA and FDA aim to slash Gaucher disease R&D costs
https://pharmaphorum.com/news/ema-fda-encourage-gaucher-rd/
Proposals include multi-company trial.
